SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
American Journal of Hospice and Palliative Medicine®
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
1049909109333928v1
26/4/281    most recent
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Younis, T.
Right arrow Articles by Levine, E.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Younis, T.
Right arrow Articles by Levine, E.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Length of Survival in Hospice for Cancer Patients Referred From a Comprehensive Cancer Center

Tallal Younis, MBBCh, FRCP

Queen Elizabeth Health Sciences Centre, Halifax, Nova Scotia, Canada, tallal.younis{at}cdha.nshealth.ca

Robert Milch, MD

The Center for Hospice and Palliative Care, Buffalo, New York

Nawal Abul-Khoudoud, MD

Private Practice, Thief River Falls, Minnesota

David Lawrence

Roswell Park Cancer Institute, Buffalo, New York

Amy Mirand, PhD

and Frontier Science & Technology Research Foundation, Buffalo, New York

Ellis Levine, MD

Roswell Park Cancer Institute, Buffalo, New York

This retrospective study examined 180 hospice patients referred from a comprehensive cancer center over 6 months in 2002 to (1) identify the variables associated with shorter length of survival (LOS) in hospice and (2) examine the LOS in hospice for those who previously participated in clinical trials and/or phase I studies. The median LOS in hospice for this cohort was 35 days. In multivariate analysis, low Palliative Performance Score (PPS) at hospice enrollment and male gender were associated with shorter LOS in hospice: males with low PPS had the shortest LOS while females with high PPS had the longest LOS. No correlation was found between the LOS in hospice and prior participation in clinical trials and/or phase I studies.

Key Words: survival • hospice • cancer • malignancy • palliation • clinical trial • phase I study • prognosis

This version was published on August 1, 2009

American Journal of Hospice and Palliative Medicine®, Vol. 26, No. 4, 281-287 (2009)
DOI: 10.1177/1049909109333928
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement